SPI ex SLI
5.390,05
PKT
+8,74
PKT
+0,16
%
Werbung
Analysen zu SPI ex SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.01.05 | BB Biotech Kaufen | Hamburger Sparkasse | |
| 19.01.05 | OC Oerlikon Buy | Helvea | |
| 19.01.05 | Barry Callebaut Neutral | Helvea | |
| 19.01.05 | OC Oerlikon Neutral | Sarasin Research | |
| 19.01.05 | OC Oerlikon Accumulate | Helvea | |
| 19.01.05 | Komax Neutral | Helvea | |
| 18.01.05 | Sulzer Buy | Sarasin Research | |
| 18.01.05 | Swiss Prime Site Neutral | Helvea | |
| 18.01.05 | OC Oerlikon Buy | Helvea | |
| 20.01.05 | Rieter Buy | Helvea | |
| 18.01.05 | Swiss Prime Site Neutral | Helvea | |
| 20.01.05 | OC Oerlikon Accumulate | Helvea | |
| 24.01.05 | Helvetia Baloise Reduce | Sal. Oppenheim | |
| 20.01.05 | Sulzer Buy | Helvea | |
| 18.01.05 | Siegfried Neutral | Helvea | |
| 20.01.05 | Helvetia Baloise Outperform | Goldman Sachs | |
| 18.01.05 | Inficon Buy | Sarasin Research | |
| 17.01.05 | Swiss Prime Site Neutral | Sarasin Research | |
| 14.01.05 | Clariant Outperform | HypoVereinsbank | |
| 17.01.05 | Basilea Pharmaceutica Outperform | Credit Suisse First Boston | |
| 14.01.05 | Rieter Neutral | Credit Suisse First Boston | |
| 17.01.05 | Tecan (N) Neutral | Credit Suisse First Boston | |
| 13.01.05 | Sulzer Buy | Sarasin Research | |
| 04.01.05 | dormakaba Buy | Sarasin Research |